Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / I•••• H••••••••• D•••

F•••••••• P••••••• to Acquire I•••• H••••••••• D••• and Analytics Assets

Platform acquisitionannouncedannounced Jan 21, 2022Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
technology / analytics
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • E••• P••••••Deal partnerconfirmed
    “We have followed IBM’s journey in healthcare data and analytics for a number of years and have a deep appreciation for its portfolio of innovative healthcare products,” said E••• P••••••, Co-President at F•••••••• P•••••••.
  • J••••• C•••Deal partnerconfirmed
    J••••• C•••, Principal at F•••••••• P•••••••, added, “Partnering with corporations to execute divisional carve-outs has been a core focus of F•••••••• P•••••••.
  • January 21, 2022 – IBM (NYSE: IBM) and F•••••••• P•••••••, a leading global investment firm that specializes in partnering with technology businesses, today announced that the companies have signed a definitive agreement under which F•••••••• P••••••• will acquire healthcare data and analytics asset
Side not stated
Evidence
F•••••••• P••••••• to Acquire I•••• H••••••••• D••• and Analytics Assets
F•••••••• P••••••• to Acquire I•••• H••••••••• D••• and Analytics Assets | Private Equity Intelligence | DFX